Quantum-Inspired Molecular Docking for Drug Discovery Targeting Biochemical Pathways
DOI:
https://doi.org/10.62802/ab9rd645Keywords:
molecular docking, drug discovery, quantum-inspired algorithms, biochemical pathways, computational chemistry, target identification, optimization methodsAbstract
Molecular docking is a central technique in drug discovery, enabling the prediction of interactions between small molecules and biological targets within complex biochemical pathways. However, classical docking algorithms often face limitations when navigating high-dimensional conformational spaces, accounting for protein flexibility, and identifying optimal binding configurations across large compound libraries. This study explores the application of quantum-inspired molecular docking frameworks as an alternative approach to address these challenges. By drawing on principles such as superposition-inspired parallel search, probabilistic state exploration, and optimization heuristics derived from quantum computing, quantum-inspired models aim to enhance docking accuracy and computational efficiency without requiring fully fault-tolerant quantum hardware. Through qualitative synthesis of research in computational chemistry, drug design, and quantum-inspired optimization, this paper examines how these methods can improve the identification of biologically relevant binding poses and pathway-specific targets. The analysis highlights potential advantages in modeling multi-target interactions, allosteric effects, and pathway-level drug responses. The findings suggest that quantum-inspired docking approaches offer a promising framework for accelerating early-stage drug discovery and for advancing precision medicine by enabling more robust exploration of biochemical interaction networks. Ultimately, this study positions quantum-inspired molecular docking as a scalable and forward-looking strategy for targeting complex biological systems.
References
de Angelo, R. M., de Sousa, D. S., da Silva, A. P., Chiari, L. P., da Silva, A. B., & Honorio, K. M. (2025). Molecular Docking: State-of-the-Art Scoring Functions and Search Algorithms. In Computer-Aided and Machine Learning-Driven Drug Design: From Theory to Applications (pp. 163-198). Cham: Springer Nature Switzerland.
Elgawish, M. S., Almatary, A. M., Zaitone, S. A., & Salem, M. S. (2025). Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects. RSC Medicinal Chemistry, 16(10), 4698-4720.
Katari, T. (2025). Quantum-Inspired Drug Discovery Model (Doctoral dissertation, CALIFORNIA STATE UNIVERSITY NORTHRIDGE).
Kumar, V., & Roy, K. (2025). Embracing the changes and challenges with modern early drug discovery. Expert Opinion on Drug Discovery, 20(4), 419-431.
Neumann, A., & Klein, R. (2025). A benchmark set of bioactive molecules for diversity analysis of compound libraries and combinatorial chemical spaces. Journal of Chemical Information and Modeling, 65(17), 9097-9124.
Sun, Q., & Zhao, G. (2025). Network toxicology and machine learning reveal key molecular targets and pathways of mono-2-ethylhexyl phthalate-induced atherosclerosis. Drug and Chemical Toxicology, 1-13.
Ur Rehman, J., Ulum, M. S., Shaffar, A. W., Hakim, A. A., Abdullah, Z., Al-Hraishawi, H., ... & Shin, H. (2025). Evolutionary Algorithms and Quantum Computing: Recent Advances, Opportunities, and Challenges. IEEE Access.
Wang, Y., Li, Y., Chen, J., & Lai, L. (2025). Modeling protein–ligand interactions for drug discovery in the era of deep learning. Chemical Society Reviews.
Zhang, S., Liu, K., Liu, Y., Hu, X., & Gu, X. (2025). The role and application of bioinformatics techniques and tools in drug discovery. Frontiers in Pharmacology, 16, 1547131.